Trough-to-peak ratios and elimination half-lives of antihypertensive drugs: implications for 24-hour blood pressure control in primary care.

Aten PrimariaJul 3, 2026 (epub)
Clinical ResearchCardiologyInternal Medicine (General)Open access

Mar Serrat-Costa, Gabriel Coll de Tuero, Ernest Vinyoles Bargalló et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review compiled trough-to-peak (TP) ratios and elimination half-lives of 83 antihypertensive drugs from 228 publications. It found substantial variability in TP ratios and half-lives across different pharmacological classes. The findings aim to enhance understanding of 24-hour blood pressure control and inform treatment selection in clinical practice.

Key findings

  • TP ratios were available for 69 antihypertensive drugs.
  • Elimination half-life values were reported for 77 antihypertensive drugs.
  • Substantial variability in TP ratios and half-lives was observed across pharmacological classes.

Why it matters

Understanding the pharmacokinetics of antihypertensive medications is crucial for optimizing 24-hour blood pressure control, which can improve patient outcomes and guide treatment decisions in primary care.

Source

Published in Aten Primaria. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.